Clinical Trials Directory

Trials / Completed

CompletedNCT03706378

Food Modification to Alter Glycaemia and Insulinaemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Singapore Institute of Food and Biotechnology Innovation · Other Government
Sex
Male
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The study specifically aims to determine glycemic and insulinemic response of added low GI ingredients, beta-glucan, resistant starch and isomaltulose to foods.

Detailed description

There will be a total of 9 test sessions and each session will last up to 3 hours. At each test session, the following procedures will be performed: two finger-prick blood samples, five minutes apart to measure baseline blood glucose and insulin concentrations. Subject will be served the test food and to consume within15 minutes. Following the test meal, blood samples will be collected at the following time points: 15, 30, 45, 60, 90, 120, 150 and 180min for glucose measurements and insulin measurements will be collected at 30, 60, 90, 120, 150 and 180min.

Conditions

Interventions

TypeNameDescription
OTHERGlucose Reference 1Glucose contains 50g of available carbohydrates
OTHERGlucose Reference 2Glucose contains 50g of available carbohydrates
OTHERGlucose Reference 3Glucose contains 50g of available carbohydrates
OTHERWheat Yellow NoodleWheat Yellow Noodle will contain 50g of available carbohydrate
OTHERBeta-glucan yellow NoodleBeta-glucan yellow noodle will contain 50g of available carbohydrate
OTHERRice RollRice Roll will contain 50g of available carbohydrate
OTHERRice Roll with resistant starchRice Roll fortified with resistant starch will contain 50g of available carbohydrate
OTHERSucrose JellyJelly and bread will contain 50g of available carbohydrate. The jelly will contain 25g of sucrose
OTHERIsomaltulose JellyJelly and bread will contain 50g of available carbohydrate. The jelly will contain 25g of Isomaltulose

Timeline

Start date
2017-08-18
Primary completion
2019-04-04
Completion
2019-04-04
First posted
2018-10-16
Last updated
2019-05-13

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03706378. Inclusion in this directory is not an endorsement.